233 related articles for article (PubMed ID: 23095282)
21. The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis.
Tikiz H; Arslan O; Pirildar T; Tikiz C; Bayindir P
Anadolu Kardiyol Derg; 2010 Apr; 10(2):98-103. PubMed ID: 20382605
[TBL] [Abstract][Full Text] [Related]
22. Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial.
Erhayiem B; Pavitt S; Baxter P; Andrews J; Greenwood JP; Buch MH; Plein S
Trials; 2014 Nov; 15():436. PubMed ID: 25381560
[TBL] [Abstract][Full Text] [Related]
23. The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study.
Sandoo A; Kitas GD; Carroll D; Veldhuijzen van Zanten JJ
Arthritis Res Ther; 2012 May; 14(3):R117. PubMed ID: 22594788
[TBL] [Abstract][Full Text] [Related]
24. Arterial Inflammation Detected With
Geraldino-Pardilla L; Zartoshti A; Bag Ozbek A; Giles JT; Weinberg R; Kinkhabwala M; Bokhari S; Bathon JM
Arthritis Rheumatol; 2018 Jan; 70(1):30-39. PubMed ID: 28992382
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].
Benucci M; Turchini S; Parrochi P; Boccaccini P; Manetti R; Cammelli E; Manfredi M
Recenti Prog Med; 2006 Mar; 97(3):134-9. PubMed ID: 16700418
[TBL] [Abstract][Full Text] [Related]
26. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
Duffy TN; Genta M; Moll S; Martin PY; Gabay C
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
[No Abstract] [Full Text] [Related]
27. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis.
Del Porto F; Laganà B; Lai S; Nofroni I; Tinti F; Vitale M; Podestà E; Mitterhofer AP; D'Amelio R
Rheumatology (Oxford); 2007 Jul; 46(7):1111-5. PubMed ID: 17449484
[TBL] [Abstract][Full Text] [Related]
28. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
Cole P; Rabasseda X
Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
30. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.
Migliore A; Massafra U; Bizzi E; Argento G; Diamanti AP; Germano V; Tormenta S; Arduini F; Iannessi F; Granatas M; Laganà B
Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):363-9. PubMed ID: 22530354
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.
Bilsborough W; Keen H; Taylor A; O'Driscoll GJ; Arnolda L; Green DJ
Rheumatol Int; 2006 Oct; 26(12):1125-31. PubMed ID: 16799778
[TBL] [Abstract][Full Text] [Related]
32. Effects of TNF inhibitor on innate inflammatory and Th17 cytokines in stimulated whole blood from rheumatoid arthritis patients.
Zivojinovic S; Pejnovic N; Sefik-Bukilica M; Kovacevic L; Soldatovic I; Bugarski D; Mojsilovic S; Damjanov N
Inflammopharmacology; 2012 Dec; 20(6):323-30. PubMed ID: 22733231
[TBL] [Abstract][Full Text] [Related]
33. Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis.
Vassilopoulos D; Gravos A; Vlachopoulos C; Kandili A; Ioakeimidis N; Pectasides D; Stefanadis C
Clin Rheumatol; 2015 Feb; 34(2):359-64. PubMed ID: 24928345
[TBL] [Abstract][Full Text] [Related]
34. Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept.
Umekita K; Miyauchi S; Ueno S; Takajo I; Kusumoto K; Hasuike S; Umekita Y; Tanaka H; Nagata K; Nagatomo Y; Kataoka H; Shimoda K; Okayama A
Intern Med; 2011; 50(11):1245-9. PubMed ID: 21628943
[TBL] [Abstract][Full Text] [Related]
35. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
[TBL] [Abstract][Full Text] [Related]
36. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin.
Chen CY; Tsai CY; Lee PC; Lee SD
Curr Pharm Des; 2013; 19(10):1956-64. PubMed ID: 23305268
[TBL] [Abstract][Full Text] [Related]
37. The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness.
Angel K; Provan SA; Mowinckel P; Seljeflot I; Kvien TK; Atar D
Atherosclerosis; 2012 Nov; 225(1):160-5. PubMed ID: 23014354
[TBL] [Abstract][Full Text] [Related]
38. Anti-TNF agents for rheumatoid arthritis.
Seymour HE; Worsley A; Smith JM; Thomas SH
Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
[TBL] [Abstract][Full Text] [Related]
39. Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial.
Liao KP; Rist P; Giles J; Santacroce L; Connelly MA; Glynn RJ; Ridker P; Tawakol A; Bathon J; Solomon DH
Arthritis Res Ther; 2024 Jun; 26(1):123. PubMed ID: 38915065
[TBL] [Abstract][Full Text] [Related]
40. Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis.
Soubrier M; Jouanel P; Mathieu S; Poujol D; Claus D; Dubost JJ; Ristori JM
Joint Bone Spine; 2008 Jan; 75(1):22-4. PubMed ID: 17888710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
